April 5, 2010 Attention: Dr. Neil Riordan Dr. Thomas Ichim Medistem, Inc. Re: Acquisition of Share Equity of Medistem, Inc, a Nevada corporation Gentlemen:Acquisition Agreement • April 13th, 2010 • Entest Biomedical, Inc. • Women's, misses', and juniors outerwear
This letter confirms our understanding of the mutual present intentions of Entest BioMedical, Inc. (the "Purchaser"), Medistem, Inc. (“Company”) and Dr. Neil Riordan, AIDAN Research and Consulting LLC and Aidan Foundation (collectively the "Seller") with respect to the principal terms and conditions under which the Purchaser will acquire approximately 61.4495% of the outstanding capital stock of the Company. Seller represents there are 4,977,976 common shares outstanding and no other classes of stock outstanding. Such transaction is hereinafter referred to as the "Acquisition."
